期刊文献+

慢性心力衰竭患者血浆脑钠肽水平与左室重构的关系和预后价值 被引量:10

Relationship between plasma brain natriuretic peptide level and left ventricular remodeling and prognostic value in chronic heart failure patients
原文传递
导出
摘要 目的探讨慢性心力衰竭(CHF)患者血浆脑钠肽水平与左室重构的关系及其预后价值。方法入选126例CHF患者,测定血浆脑钠肽(BNP)浓度,随访住院期间、30天和6个月的主要心脏不良事件(即心血管病死亡、新发心衰/心衰恶化再人院)。结果随BNP水平分级递增,左室重量指数(LVMI)、左室舒张末内径指数(LVIDdI)明显增高,左室射血分数(LVEF)明显减低,各组心脏不良事件发生率明显增加。通过多变量的logistic回归分析,BNP是独立于年龄、LVMI、LVIDdI、LVEF等危险因素的CHF预后因素,可预测30天和6个月心脏不良事件发生(r分别为0.769,0.831,P〈0.01)。BNP预测6个月心脏不良事件发生的ROC曲线下面积为0.851(95%CI:0.778~0.924,P〈0.01)。结论BNP水平与CHF患者左室重构有一定相关性,能很好地对CHF患者进行危险分层,是CHF患者近期临床预后的较好指标。 Objective To investigate the relationship between brain natriuretic peptide (BNP) level and left ventricular remodeling and prognostic value in chronic heart failure (CHF) patients. Methods The plasma BNP concentrations of 126 CHF patients were measured quickly by luminoimmunoassay. The main adverse cardiac events( MACE,including cardiavarscular death, recurrent heart failure/readmission for HF worsening) were analyzed at inhospital and 30 days and 6 months. Results With the higher BNP values in CHF group gradually, LVMI and LVIDdI increasing, and LVEF decreasing distinctly with the higher incidence of MACE. After adjustment for clinical prognostic factors, such as ages, LVMI, LVIDdI, and LYEF in CHF groups, BNP level remained significantly independent predictor for MACE at 30 days ( r = 0. 769, P 〈 0.01 ) and 6 months ( r = 0.831, P 〈 0.01 ) by multivariate logistic regression analysis. The Area under receiver operating characteristic (ROC) curve was 0.851 (95% CI 0. 778 - 0. 924, P 〈 0.01 ) for incidence of MACE at 6 months. Conclusion Plasma BNP level is related with left ventricular remodeling, and it is a significantly independent predictor for MACE in patients with CHF.
出处 《临床内科杂志》 CAS 2008年第12期818-820,共3页 Journal of Clinical Internal Medicine
关键词 充血性心力衰竭 B型利钠肽 脑钠肽 Chronic heart failure Brain natriuretic peptide BNP
  • 相关文献

参考文献7

  • 1Almeida P, Azevedo A, Rodrigues R, et al. B-type natriuretie peptide and left ventricular hypertrophy in hypertensive patients. Rev-Port-Cardiol,2003 ,22 :327-336. 被引量:1
  • 2Vasan, R S, Benjamin E J, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002, 288: 1252- 1259. 被引量:1
  • 3胡咏梅,赵思勤,李秋,聂晓莉,吴涛,刘小蓉,王勉,张文勇.慢性心力衰竭患者血浆脑钠肽和内皮素-1水平与血流动力学的相关性[J].临床心血管病杂志,2006,22(11):672-674. 被引量:27
  • 4Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. NEJM,2004,350:655- 663. 被引量:1
  • 5Tsutamoto T, Wado A, Maedo K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997,96 : 509 -516. 被引量:1
  • 6张书富,华尔铨,何祚佑,郑鹏翔,陈德,徐虹,马瑾,周依蒙,张斌.快速测定脑利钠肽预测充血性心力衰竭患者预后的价值[J].临床内科杂志,2004,21(8):522-523. 被引量:8
  • 7Berger R, Huelsmann M, Strecker K, et al. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur J Clin Invest,2005,35:24-31. 被引量:1

二级参考文献16

  • 1张书富,徐龙,华尔铨,何祚佑,郑鹏翔,陈德,张斌,周依蒙,马瑾,李海玲,任方.快速测定脑钠肽在急诊呼吸困难患者中的临床应用[J].中华医学杂志,2003,83(21):1921-1921. 被引量:7
  • 2Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.Circulation,1997,96(2):509-516. 被引量:1
  • 3Anand IS,Fisher LD,Chiang YT,et al.Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial(Val-HeFT).Circulation,2003,107 (9):1278-1283. 被引量:1
  • 4Harrison A,Morrison LK,Krishnaswamy P,et al.B-type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea.Ann of Emerg Med,2002,39 (2):131-138. 被引量:1
  • 5Levin ER,Gardner DG,Samson WK.Natriuretic peptides.N Engl J Med,1998,339(5):321-328. 被引量:1
  • 6Cheng V,Kazanagra R,Garcia A,et al.A rapid bedside test for B-type peptides predicts treatment outcomes in patients admitted for decompensated heart failure:a pilot study.J Am Coll Cardiol,2001,37 (2):386-391. 被引量:1
  • 7GROENNING B A, NILSSON J C, SONDERGAARD L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [J].Eur J Heart Fail, 2001,3:699-708. 被引量:1
  • 8BARTON M, KIOWSKI W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease[J]. Curr Hypertens Rep, 2001,3:322- 330. 被引量:1
  • 9BOULANGER C M. Secondary endothelial dysfunction: hypertension and heart failure[J]. J Cell Cardiol, 1999,31: 39-49. 被引量:1
  • 10YAMAMOTO K, BURNETT J, BERMUDEZ E A, et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction[J]. J Card Fail, 2000,6:194-200. 被引量:1

共引文献32

同被引文献54

引证文献10

二级引证文献194

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部